Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Capital Expenditures (2017 - 2023)

Purple Biotech has reported Capital Expenditures over the past 6 years, most recently at $52000.0 for Q4 2022.

  • Quarterly Capital Expenditures rose 966.67% to $52000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $26000.0 through Dec 2022, up 121.49% year-over-year, with the annual reading at $3000.0 for FY2025, N/A changed from the prior year.
  • Capital Expenditures was $52000.0 for Q4 2022 at Purple Biotech, up from -$6000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $52000.0 in Q4 2022 and troughed at -$156000.0 in Q4 2020.
  • The 5-year median for Capital Expenditures is -$6000.0 (2021), against an average of -$24090.9.
  • Year-over-year, Capital Expenditures crashed 5100.0% in 2020 and then surged 966.67% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at -$11000.0 in 2018, then surged by 72.73% to -$3000.0 in 2019, then crashed by 5100.0% to -$156000.0 in 2020, then skyrocketed by 96.15% to -$6000.0 in 2021, then surged by 966.67% to $52000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Capital Expenditures are $52000.0 (Q4 2022), -$6000.0 (Q3 2022), and -$6000.0 (Q2 2022).